> CPDR News 2010
CPDR's ERG Antibody Leads to Successful Opportunities
February 14, 2011
The Center for Prostate Disease Research (CPDR) and the Uniformed Services University of the Health Sciences (USUHS) - with the Henry M. Jackson Foundation (HJF) for the Advancement in Military Medicine - are excited to announce a licensing agreement with Biocare Medical for the exclusive worldwide sales and distribution of the anti-ERG monoclonal antibody (ERG-MAb).
This antibody has potential to be used for in vitro diagnostics, prognostics, patient monitoring, and screening by immunohistochemistry. The CPDR-USUHS collaborative research endeavor also involves investigators from the Walter Reed Army Medical Center, the Armed Forces Institute of Pathology, and Biocare Medical to further study the ERG-MAb and its clinical diagnostic potential.
